Alnylam Pharmaceuticals reported $-146160000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -43.71M 23.06M
Agios Pharmaceuticals AGIO:US $ -89.22M 2M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Alnylam Pharmaceuticals ALNY:US $ -146.16M 40.09M
Amgen AMGN:US $ 828M 1301M
Arena Pharmaceuticals ARNA:US $ -144.39M 12.4M
Arrowhead Research ARWR:US $ -31868000 3.64M
Avrobio Inc AVRO:US -31375000 4.49M
Biocryst Pharmaceuticals BCRX:US $ -29.58M 21.8M
Biomarin Pharmaceutical BMRN:US $ 11.67M 13.41M
Bluebird Bio BLUE:US $ -240.84M 9.63M
Dicerna Pharmaceuticals DRNA:US $ -40.24M 11.14M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Intercept Pharmaceuticals ICPT:US $ 0.76M 30.11M
IONIS PHARMACEUT IONS:US $ -81.6M 10.38M
Mirati Therapeutics MRTX:US $ -164.19M 31.76M
Moderna Inc MRNA:US 3.06B 1.8B
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Novartis NVS:US $ 3479M 1064M
Ptc Therapeutics PTCT:US $ -98.49M 0.34M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Regulus Therapeutics RGLS:US $ -6.64M 0.84M
Sangamo Biosciences SGMO:US $ -48.7M 2.4M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
Xencor XNCR:US $ 9.09M 24.76M
YTE INCY:US $ 140.84M 42.04M